سعر تينولات اس ار Tenolate s.r‏ 20 كبسولة 2026

Fixed combination of atenolol (beta1-selective blocker) and nifedipine (dihydropyridine calcium channel blocker) sustained-release capsules (Sigma / Hochster).

• Flushing, oedema, headache, dizziness, gastrointestinal disturbance and fatigue; mostly at treatment start or high doses.International label, equivalent formulation · Health Products Regulatory Authority (HPRA)

• Hypersensitivity to atenolol, nifedipine or other dihydropyridines; history of wheezing/asthma or bronchospasm; women capable of child-bearing and nursing mothers; second/third degree heart block, sick sinus syndrome, sino-atrial block, overt or decompensated heart failure.International label, equivalent formulation · Health Products Regulatory Authority (HPRA)

• Contraindicated in women capable of child-bearing; nifedipine safety in pregnancy not established, with embryotoxicity and teratogenicity in animals at maternally toxic doses.International label, equivalent formulation · Health Products Regulatory Authority (HPRA)
• Contraindicated in nursing mothers as nifedipine and atenolol may be present in breast milk.International label, equivalent formulation · Health Products Regulatory Authority (HPRA)

• Atenolol: Beta1-selective beta-adrenergic receptor blocker without membrane-stabilizing or intrinsic sympathomimetic activity; selectivity is not absolute at higher doses (US label).